Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
Clinical trial NCT04279769 · COMPLETED
Trial details
- NCT number
- NCT04279769
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2021-11-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.